Guggenheim analyst Seamus Fernandez lowered the price target on Vaxcyte (NASDAQ: PCVX) to $116.00 (from $160.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE